These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8713803)
1. Heparin-induced thrombocytopenia: discrepancy between the presence of IgG cross-reacting in vitro with fraxiparine and its successful clinical use. Luzzatto G; Cordiano I; Patrassi G; Fabris F Thromb Haemost; 1996 Jan; 75(1):211-2. PubMed ID: 8713803 [No Abstract] [Full Text] [Related]
2. Heparin-induced thrombocytopenia: discrepancy between the presence of IgG cross-reacting in vitro with fraxiparine and its successful clinical use. Luzzatto G; Cordiano I; Patrassi G; Fabris F Thromb Haemost; 1995 Dec; 74(6):1607-9. PubMed ID: 8772246 [No Abstract] [Full Text] [Related]
5. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment. Kelton JG Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026 [No Abstract] [Full Text] [Related]
6. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid. Newman PM; Swanson RL; Chong BH Thromb Haemost; 1998 Aug; 80(2):292-7. PubMed ID: 9716155 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis. Davenport A Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318 [No Abstract] [Full Text] [Related]
8. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies. Selleng K; Warkentin TE; Sheppard JA; Greinacher A Transfusion; 2009 Sep; 49(9):1812-8. PubMed ID: 19497062 [TBL] [Abstract][Full Text] [Related]
9. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med; 2001 Oct; 135(7):S-45. PubMed ID: 11596575 [No Abstract] [Full Text] [Related]
10. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229 [TBL] [Abstract][Full Text] [Related]
13. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367 [TBL] [Abstract][Full Text] [Related]
14. Testing for heparin-induced thrombocytopenia antibodies. Warkentin TE; Sheppard JA Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164 [TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia as an autoimmune disease--idiotypic evidence for the role of anti-heparin/PF4 autoantibodies. Shoenfeld Y Isr J Med Sci; 1997 Apr; 33(4):243-5. PubMed ID: 9347871 [No Abstract] [Full Text] [Related]
17. Heparin-induced thrombocytopenia, a prothrombotic disease. Levy JH; Hursting MJ Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119 [TBL] [Abstract][Full Text] [Related]
20. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test. Dellaria SM; Greilich PE; Sarode R Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]